English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/213229
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:

Title

MEN1-associated primary hyperparathyroidism in the Spanish Registry: clinical characterictics and surgical outcomes

AuthorsLamas, Cristina; Navarro-Villarán, Elena; Casterás, Anna; Portillo, Paloma; Alcázar, Victoria; Calatayud, María; Álvarez-Escolá, Cristina; Sastre, Julia; Boix, Evangelina; Forga, Luis; Vicente, Almudena; Oriola, Josep; Mesa, Jordi; Valdés, Nuria
KeywordsMultiple endocrine neoplasia type 1
MEN1 gene
Primary hyperparathyroidism
Parathyroidectomy
Hypoparathyroidism
Issue Date2019
PublisherEuropean Society of Endocrinology
Society for Endocrinology
CitationEndocrine Connections 8(10): 1416-1424 (2019)
AbstractPrimary hyperparathyroidism is the most frequent manifestation of multiple endocrine neoplasia type 1 (MEN1) syndrome. Bone and renal complications are common. Surgery is the treatment of choice, but the best timing for surgery is controversial and predictors of persistence and recurrence are not well known. Our study describes the clinical characteristics and the surgical outcomes, after surgery and in the long term, of the patients with MEN1 and primary hyperparathyroidism included in the Spanish Registry of Multiple Endocrine Neoplasia, Pheochromocytomas and Paragangliomas (REGMEN). Eighty-nine patients (49 men and 40 women, 34.2 ± 13 years old) were included. Sixty-four out of the 89 underwent surgery: a total parathyroidectomy was done in 13 patients, a subtotal parathyroidectomy in 34 and a less than subtotal parathyroidectomy in 15. Remission rates were higher after a total or a subtotal parathyroidectomy than after a less than subtotal (3/4 and 20/22 vs 7/12, P < 0.05), without significant differences in permanent hypoparathyroidism (1/5, 9/23 and 0/11, N.S.). After a median follow-up of 111 months, 20 of the 41 operated patients with long-term follow-up had persistent or recurrent hyperparathyroidism. We did not find differences in disease-free survival rates between different techniques, patients with or without permanent hypoparathyroidism and patients with different mutated exons, but a second surgery was more frequent after a less than subtotal parathyroidectomy.
Description© 2019 The authors.
Publisher version (URL)http://dx.doi.org/10.1530/EC-19-0321
URIhttp://hdl.handle.net/10261/213229
DOIhttp://dx.doi.org/10.1530/EC-19-0321
ISSN2049-3614
E-ISSN2049-3614
Appears in Collections:(IBIS) Artículos
Files in This Item:
File Description SizeFormat 
MEN1_associated_Lamas_Art2019.pdf734,05 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.